SwitzerReport

Independent. Trusted. Proven.

Investing

Investment analysis, share recommendations, and market insights.

How would I invest cash right now? — Investing, Super & SMSF
Premium

How would I invest cash right now?

I’ve been looking for recommendations for two of my financial planning clients. I’ll share with you what I’ve come up with. Be clear on this: if they were full-on growth investors, then I’d be more aggressive.

Peter Switzer · May 5, 2025
‘HOT’ stock: Iress Limited (IRE) — Investing
Premium

‘HOT’ stock: Iress Limited (IRE)

In our “HOT” stock column today, Raymond Chan, Head of Asian Desk at Morgans, explains that Morgans sees Iress Limited (IRE) providing investors a decent upside ‘option’.

Maureen Jordan · May 5, 2025
4 software stars — Investing
Premium

4 software stars

Here’s a look at four ASX companies that say they’re global leaders, and are hoping to be the next WiseTech, replicating what it has done in the global logistics industry.

James Dunn · May 5, 2025
“HOT” stock: Boss Energy (BOE) — Investing
Premium

“HOT” stock: Boss Energy (BOE)

In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, says Boss Energy (BOE) is a stock he likes because over the next several years the amount of uranium supply coming online isn’t enough to meet current demand.

Maureen Jordan · May 1, 2025
I’m a believer in these six plays — Investing
Premium

I’m a believer in these six plays

The investments I talked about today are linked to what I think are believable future scenarios. All of them have terrific upside potential, but you just might have to be patient with a few of them.

Peter Switzer · April 28, 2025
Has BOQ turned the corner? — Investing
Premium

Has BOQ turned the corner?

While Bendigo has struggled in recent times, last week it announced its results for the first half and the stock rallied 13% on the announcement. Has it turned the corner? Let’s take a closer look…

Paul Rickard · April 28, 2025
HOT” stock: Resmed (RMD) — Investing
Premium

HOT” stock: Resmed (RMD)

Raymond Chan, Head of Asian Desk at Morgans, is again a fan of Resmed (RMD). In our “HOT STOCK” column today, Raymond goes through the reasons why he continues to believe RMD is an ADD to an investor’s portfolio.

Maureen Jordan · April 28, 2025

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.